Leczenie nowotworu neuroendokrynnego trzustki w Izraelu: proszę uzyskać zestawienie top-3 klinik dla siebie

Prof. Merimsky kieruje Oddziałem Onkologii Tkanek Miękkich i Kości w Centrum Medycznym Sourasky — jest to największy program leczenia mięsaków w Izraelu.

• Od ponad 25 lat specjalizuje się w nowotworach neuroendokrynnych
• Członek panelu ekspertów ESMO ds. leczenia mięsaków
• Odbył staż specjalistyczny w Institut Gustave Roussy w Paryżu
• Jest autorem licznych publikacji na temat leczenia rzadkich nowotworów

Dr Pelles Sharon specjalizuje się w nowotworach neuroendokrynnych trzustki. W Centrum Medycznym Sourasky oferuje zaawansowane metody leczenia, takie jak operacja Whipple’a oraz chemia wewnątrzbrzuszna w hipertermii (HIPEC).

• Posiada doświadczenie w szerokim zakresie operacji onkologicznych i terapii przeciwnowotworowych.
• Prowadzi badania kliniczne, aby pomóc pacjentom lepiej zrozumieć przebieg badań testowych.
• Zapewnia spersonalizowane plany leczenia, obejmujące immunoterapię oraz terapię celowaną.

Dr. Arnon Nagler is an internationally recognized hematologist and bone marrow transplant expert. He is a Professor of Medicine at Tel Aviv University. He is Director Emeritus of Hematology & Bone Marrow Transplantation and the Cord Blood Bank at Sheba Medical Center. He earned his M.D. from the Hebrew University–Hadassah and an M.Sc. in hematopoiesis from Tel Aviv University. He completed postdoctoral training at Stanford. He is board certified in internal medicine and hematology.

He has more than 35 years of experience. He pioneered reduced‑intensity allogeneic transplant protocols for malignant and non‑malignant diseases. He founded Israel’s first public cord blood bank. He performed the country’s first cord blood transplants.

He has held international leadership roles. He served as Chair and Co‑Chair of the ALWP of the EBMT. He was a vice‑chair and long‑term member of EBMT committees. He served on the board of NetCord/EuroCord and as treasurer. He is a frequent invited speaker. He has published widely in journals such as Blood and Leukemia. He has led major clinical trials as a principal investigator and held editorial roles. He has received multiple awards for innovation and clinical excellence.

Prof. Ido Nachmany heads the Second Surgical Department at Sheba Medical Center. He specializes in HPB and robotic surgery for diseases of the liver, pancreas, and bile ducts, and for gastrointestinal neuroendocrine tumors. He also performs adrenal, spleen, and stomach surgery. Forbes listed him among Israel’s top physicians.

He advances minimally invasive robotic and laparoscopic techniques. The aim is better precision and faster recovery.

Credentials: Senior Lecturer at Tel Aviv University. Member of ASTS and IHPBA. Completed HPB and abdominal transplant fellowships at the Thomas E. Starzl Transplantation Institute. Board certified in General Surgery (Israel), Abdominal Organ Transplantation (ASTS), and HPB Surgery (University of Pittsburgh). He has published in Cancer Research, the Journal of the American College of Surgeons, and the European Journal of Surgical Oncology.